CRYBG1
Basic information
Region (hg38): 6:106360717-106572017
Previous symbols: [ "ST4", "AIM1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRYBG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 103 | 108 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 0 | 103 | 11 | 4 |
Variants in CRYBG1
This is a list of pathogenic ClinVar variants found in the CRYBG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-106512388-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
6-106512402-G-C | not specified | Uncertain significance (Oct 26, 2022) | ||
6-106512468-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
6-106512507-G-C | not specified | Uncertain significance (Jun 18, 2021) | ||
6-106512513-A-G | not specified | Uncertain significance (Jun 06, 2023) | ||
6-106512561-G-T | not specified | Uncertain significance (Oct 20, 2023) | ||
6-106512592-C-A | not specified | Uncertain significance (Dec 19, 2023) | ||
6-106512720-G-T | not specified | Uncertain significance (Sep 01, 2021) | ||
6-106512732-G-A | not specified | Uncertain significance (Jul 17, 2023) | ||
6-106512784-C-T | not specified | Uncertain significance (Jun 28, 2022) | ||
6-106512814-C-T | not specified | Likely benign (Jun 11, 2024) | ||
6-106512825-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
6-106512832-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
6-106512924-C-G | not specified | Uncertain significance (Sep 27, 2022) | ||
6-106512945-G-A | not specified | Uncertain significance (Aug 10, 2023) | ||
6-106512972-G-T | not specified | Uncertain significance (Apr 08, 2024) | ||
6-106512996-C-A | not specified | Uncertain significance (Jan 31, 2023) | ||
6-106519271-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
6-106519292-A-G | not specified | Uncertain significance (Jul 12, 2022) | ||
6-106519313-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
6-106519337-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
6-106519351-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
6-106519442-A-C | not specified | Uncertain significance (May 14, 2024) | ||
6-106519453-A-G | not specified | Likely benign (Apr 19, 2024) | ||
6-106519475-C-T | not specified | Uncertain significance (Dec 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CRYBG1 | protein_coding | protein_coding | ENST00000369066 | 20 | 58597 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.51e-33 | 0.00486 | 125199 | 1 | 548 | 125748 | 0.00219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0567 | 929 | 924 | 1.01 | 0.0000460 | 11268 |
Missense in Polyphen | 274 | 316.51 | 0.86569 | 4083 | ||
Synonymous | -0.908 | 373 | 351 | 1.06 | 0.0000191 | 3349 |
Loss of Function | 1.50 | 58 | 71.7 | 0.809 | 0.00000397 | 876 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00314 | 0.00312 |
Ashkenazi Jewish | 0.00263 | 0.00258 |
East Asian | 0.00792 | 0.00786 |
Finnish | 0.000787 | 0.000786 |
European (Non-Finnish) | 0.00157 | 0.00152 |
Middle Eastern | 0.00792 | 0.00786 |
South Asian | 0.00292 | 0.00291 |
Other | 0.00328 | 0.00310 |
dbNSFP
Source:
- Function
- FUNCTION: May function as suppressor of malignant melanoma. It may exert its effects through interactions with the cytoskeleton.;
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- rvis_EVS
- 2.11
- rvis_percentile_EVS
- 97.91
Haploinsufficiency Scores
- pHI
- 0.365
- hipred
- N
- hipred_score
- 0.416
- ghis
- 0.433
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Crybg1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- biological_process
- Cellular component
- cellular_component
- Molecular function
- molecular_function;carbohydrate binding